Change is afoot in the pharmaceutical industry. Merger-andacquisition activity is high; regulations are becoming ever more stringent; executives are becoming more cost-conscious; and companies are outsourcing more work so they can focus on key competencies. And this is just scratching the surface.
To meet these challenges, forward looking pharma leaders are completely rethinking their business processes to find ways to become faster and more efficient and gain better control over compliance and cost. Emerging requirements for speed, efficiency and transparency demand a new approach to business and the contracts that form the foundation of commerce. Whether it is buying from suppliers or engaging with HCPs or CROs for clinical studies or engagements with wholesalers and PBMs, contracts are central in improving these processes.
